Page last updated: 2024-08-24

naphthalimides and Acute Promyelocytic Leukemia

naphthalimides has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, X; Liu, J; Qian, X; Xu, K; Xu, Y1

Other Studies

1 other study(ies) available for naphthalimides and Acute Promyelocytic Leukemia

ArticleYear
B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells.
    Molecular cancer research : MCR, 2010, Volume: 8, Issue:12

    Topics: 14-3-3 Proteins; Adenine; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; DNA-Binding Proteins; Down-Regulation; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Genes, bcl-2; Genes, MDR; Genes, p53; HL-60 Cells; Humans; K562 Cells; Leukemia, Promyelocytic, Acute; Naphthalimides; Organophosphonates; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; U937 Cells

2010